Stelma, F., van der Ree, M., Sinnige, M., Brown, A., Swadling, L., de Vree, J., . . . Reesink, H. (2017). A single dose of anti-miR-122, RG-101, in CHC patients results in NK cell normalization with no effect on HCV-specific CD8+ T cell function. Wiley.
Chicago Style (17th ed.) CitationStelma, F., et al. A Single Dose of Anti-miR-122, RG-101, in CHC Patients Results in NK Cell Normalization with No Effect on HCV-specific CD8+ T Cell Function. Wiley, 2017.
MLA (9th ed.) CitationStelma, F., et al. A Single Dose of Anti-miR-122, RG-101, in CHC Patients Results in NK Cell Normalization with No Effect on HCV-specific CD8+ T Cell Function. Wiley, 2017.
Warning: These citations may not always be 100% accurate.